Interventional Orthopedics and How Regenexx os Reducing Self-Funded Employers MSK Costs

Executive with 30 year history working at the intersection of healthcare and large employers. Active business strategist, investor and advisor with focus on health economies and acquisitions for private and public sector. Developed multiple patented practices for streamlining insurance operations and management. CEO of Regenexx, a global best-practices provider specializing in interventional orthopedics. Architect of the Regenexx Corporate Program saving corporations millions in healthcare design. Advocate and business speaker on the unprecedented healthcare crisis, consulting with company decision makers on major strategy shifts to mitigate healthcare trajectory, leading real-time savings and employee wellbeing through innovation.